Phase I trial of 90Y-ibritumomab tiuxetan i patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation

Julie M. Vose, Philip J. Bierman, Fausto R. Loberiza, Robert G. Bociek, Daniel Matso, James O. Armitage

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of 90Y-ibritumomab tiuxetan i patients with relapsed B-cell non-Hodgkin's lymphoma following high-dose chemotherapy and autologous stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences